William K. Heiden

2017

In 2017, William K. Heiden earned a total compensation of $4.3M as President and Chief Executive Officer at AMAG Pharmaceuticals, a 44% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$553,350
Option Awards$729,274
Salary$702,973
Stock Awards$2,355,350
Other$8,100
Total$4,349,047

Heiden received $2.4M in stock awards, accounting for 54% of the total pay in 2017.

Heiden also received $553.4K in non-equity incentive plan, $729.3K in option awards, $703K in salary and $8.1K in other compensation.

Rankings

In 2017, William K. Heiden's compensation ranked 2,296th out of 14,666 executives tracked by ExecPay. In other words, Heiden earned more than 84.3% of executives.

ClassificationRankingPercentile
All
2,296
out of 14,666
84th
Division
Manufacturing
801
out of 5,768
86th
Major group
Chemicals And Allied Products
215
out of 2,074
90th
Industry group
Drugs
164
out of 1,730
91st
Industry
Pharmaceutical Preparations
129
out of 1,329
90th
Source: SEC filing on April 25, 2018.

Heiden's colleagues

We found four more compensation records of executives who worked with William K. Heiden at AMAG Pharmaceuticals in 2017.

2017

Nicholas Grund

AMAG Pharmaceuticals

Chief Commercial Officer

2017

Edward Myles

AMAG Pharmaceuticals

Chief Financial Officer

2017

Julie Krop

AMAG Pharmaceuticals

Chief Medical Officer

2017

Joseph Vittiglio

AMAG Pharmaceuticals

General Counsel

News

You may also like